"Middle Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D008875
|
| MeSH Number(s) |
M01.060.116.630
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Middle Aged".
Below are MeSH descriptors whose meaning is more specific than "Middle Aged".
This graph shows the total number of publications written about "Middle Aged" by people in this website by year, and whether "Middle Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 45 | 45 |
| 1996 | 0 | 53 | 53 |
| 1997 | 0 | 65 | 65 |
| 1998 | 0 | 51 | 51 |
| 1999 | 0 | 31 | 31 |
| 2000 | 0 | 66 | 66 |
| 2001 | 0 | 78 | 78 |
| 2002 | 0 | 109 | 109 |
| 2003 | 0 | 117 | 117 |
| 2004 | 0 | 112 | 112 |
| 2005 | 0 | 115 | 115 |
| 2006 | 0 | 119 | 119 |
| 2007 | 0 | 161 | 161 |
| 2008 | 0 | 168 | 168 |
| 2009 | 0 | 192 | 192 |
| 2010 | 0 | 212 | 212 |
| 2011 | 0 | 217 | 217 |
| 2012 | 0 | 247 | 247 |
| 2013 | 0 | 277 | 277 |
| 2014 | 0 | 277 | 277 |
| 2015 | 0 | 310 | 310 |
| 2016 | 0 | 343 | 343 |
| 2017 | 0 | 369 | 369 |
| 2018 | 0 | 298 | 298 |
| 2019 | 0 | 348 | 348 |
| 2020 | 0 | 301 | 301 |
| 2021 | 0 | 190 | 190 |
| 2022 | 0 | 54 | 54 |
| 2023 | 0 | 23 | 23 |
| 2024 | 0 | 142 | 142 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Middle Aged" by people in Profiles.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
-
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Cancer. 2025 Jan 01; 131(1):e35680.
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
-
Impacts of the US CDC recommendation on human papillomavirus vaccine uptake, 2010-2015. Front Public Health. 2024; 12:1464685.
-
COVID-19 Exacerbates Neurovascular Uncoupling and Contributes to Endothelial Dysfunction in Patients with Mild Cognitive Impairment. Biomolecules. 2024 Dec 18; 14(12).
-
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemother Pharmacol. 2024 Dec 14; 95(1):4.
-
Respiratory chronic health conditions and racial disparities associated with e-cigarette use: a cross-sectional analysis using behavioral risk factor surveillance data. Front Public Health. 2024; 12:1497745.
-
Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: A protocol for a single-arm open-label interventional trial. PLoS One. 2024; 19(12):e0314871.